
The U.S. Department of Veterans Affairs has launched a new clinical trial to determine whether semaglutide, a GLP-1 medication commonly used to treat diabetes and obesity, could also help Veterans struggling with alcohol use disorder.

The U.S. Department of Veterans Affairs has launched a new clinical trial to determine whether semaglutide, a GLP-1 medication commonly used to treat diabetes and obesity, could also help Veterans struggling with alcohol use disorder.